Clinical Trial

Comparison of Pruritus Incidence After Intrathecal Morphine 0.1 vs 0.2 mg in Cesarean Section

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 8, 2025 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study compares the incidence of pruritus (itching) requiring treatment between two doses of intrathecal morphine (0.1 mg vs 0.2 mg) when used for spinal anesthesia during cesarean section. The study aims to determine if the lower dose (0.1 mg) can reduce pruritus incidence while maintaining adequate pain relief.
Trial Details
NCT Number NCT07054775
Lead Sponsor Khon Kaen University
Conditions Pruritus Caused by Drug
Enrollment 69 participants
Start Date 2025-06-01
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-08